TP53 and exocrine pancreatic carcinoma: Eighteen patients (72%) had p53 inactivation, 7 patients (28%) had receptor tyrosine-protein kinase erbB-2(c-erbB-2) overexpression, and 11 patients (44%) showed deleted in pancreatic carcinoma locus 4(DPC4) inactivation.